AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
AFT Pharmaceuticals expands its partnership with Hikma Pharmaceuticals USA to distribute COMBOGESIC Tablets, a non-opioid pain management medication, in the US. The agreement builds on the success of the intravenous version, COMBOGESIC IV, and is expected to boost tablet sales with a profit share arrangement for AFT. The collaboration with Hikma, a major supplier of generic injectable medicines in the US, further highlights AFT’s growth strategy and commitment to providing effective pain relief solutions.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.
